Aequs Limited (AEQUS) Q2 Results FY27 Preview: Date, Time, Expectations & Key Things To Watch

Cofacto Research Published October 21, 2026 5 min read

Aequs Limited is a precision manufacturing company running integrated aerospace and consumer product ecosystems — forging, machining, surface treatment and assembly for aerospace components, plus consumer electronics, toys and durable goods. The Q2 FY 2026-2027 print will speak to whether the consumer segment's EBITDA loss keeps narrowing toward the guided Q4 FY27 breakeven, and whether the Safran wheels contract and two Tier-1 wins lift the aerospace order book above USD 1,004 Mn.

Quick Details
Results dateOctober 26, 2026
QuarterQ2 FY 2026-2027
Previous quarter revenueRs. 3,955 Mn
Previous quarter PATRs. (532) Mn
Previous quarter EBITDA margin5%
Market capRs. 16,556.02 Cr
CMPRs. 247.1

Aequs Limited Q2 Results Date and Time

The board will meet on October 26, 2026 to approve the Q2/H1 FY27 financial results; the trading window has been shut since October 1, 2026.

An earnings call for Q2 FY27 results is scheduled for October 26, 2026 at 6:00 PM IST.

What to expect from Aequs Limited's Q2 FY27 results

The quarter's test is whether the H2-weighted profitability inflection management laid out on July 29, 2026 — FY27 revenue growth of 45%-50%, operational EBITDA doubling versus FY26, and consumer EBITDA breakeven by Q4 FY27 — starts showing up in the numbers. Aerospace entered the quarter with a USD 1,004 Mn order book, up 13% QoQ and past the USD 1 billion mark, with management having said the Safran A320 wheels contract and two Tier-1 long-term agreements would reflect in the next quarter's order book. Aerospace delivered 40% YoY revenue growth at a 23% segment margin in Q1 FY27, above the guided above-20% level, while the consumer segment's EBITDA loss narrowed 24% sequentially to Rs. (361) Mn with utilization at 22% against a 40%-50% Q4 target. The rupee's 1.2% depreciation over July-September is a tailwind to USD-linked revenue and other income — the swing lever that took reported EBITDA from Rs. 279 Mn of other income in Q4 FY26 to Rs. 67 Mn in Q1 FY27. Finance costs entered the quarter after a Rs. 169 Mn sequential reduction on debt reduction, and depreciation is guided to stay at similar levels to Q1's Rs. 453 Mn for the next three quarters. The call will also be the first results under new CFO Reenah Simon Joseph, effective August 31, 2026.

Key Things To Watch

Guidance scorecard: consumer breakeven path and FY27 targets: Management's July 29, 2026 guidance set the markers this print will be measured against.

  • Consumer EBITDA breakeven — breakeven by Q4 FY27 — Q1 FY27 loss Rs. (361) Mn, narrowed 24% sequentially
  • Consumer utilization — 40%-50% by Q4 FY27 — 22% in Q1 FY27
  • Operational EBITDA — ~2x FY26 in FY27 (H2-weighted) — Rs. 148 Mn in Q1 FY27 vs Rs. 42 Mn in Q4 FY26
  • Consolidated revenue growth — 45%-50% for FY27 — +55% YoY in Q1 FY27; aerospace revenue growth — 25%-30% — +40% YoY in Q1 FY27 at a 23% segment margin

Order book and Safran wins

  • Whether the Safran A320 wheels contract and two Tier-1 long-term agreements lift the order book above USD 1,004 Mn, as management said new wins 'will reflect in the next quarter's order book'
  • Any disclosure of Safran agreement financial terms — none were disclosed for the October 12, 2026 agreements spanning A320/A330/A350/B787 across 6 Safran entities

Capex deployment and funding

  • Decision on accelerating aerospace capex — management is 'evaluating acceleration of aerospace capex plan' — and FY27 deployment vs the Rs. 660 Cr plan (Rs. 500 Cr consumer + Rs. 160 Cr aerospace)
  • Deployment of the Rs. 650 crore promoter warrant issue proceeds (Rs. 325 crore upfront at allotment) earmarked for capacity expansion including Hosur; EGM was held October 22, 2026 with no result announcement found in the retrieved announcements

Amalgamation scheme rejection and corporate events

  • Refiling decision on the Section 233 amalgamation of three wholly owned subsidiaries after the Regional Director's October 12, 2026 rejection — the company states the order has no material impact as the scheme is internal restructuring
  • Monitoring Agency observation on unutilized funds of Rs. 22.72 Cr (IPO) and Rs. 10 Cr (Pre-IPO) parked in subsidiary fixed deposits; otherwise no material deviations

Cash flow and finance costs

  • Finance cost trajectory after the Rs. 169 Mn sequential reduction to Rs. 189 Mn in Q1 FY27 on debt reduction
  • Working capital days at 125 and negative Rs. 414 Mn operating cash flow in Q1 FY27 on working capital for higher operating cycles

Frequently Asked Questions

When does Aequs expect its consumer business to break even?

Management has guided consumer EBITDA breakeven by Q4 FY27, calling it 'a major inflection point in our consolidated profitability'. The Q1 FY27 consumer EBITDA loss of Rs. (361) Mn narrowed 24% sequentially, with utilization at 22% against a 40%-50% Q4 target.

Is Aequs on track with its consumer EBITDA breakeven guidance?

Per the latest tracking, the Q1 FY27 consumer EBITDA loss of Rs. (361) Mn narrowed by Rs. 112 Mn (24%) sequentially, moving toward the Q4 FY27 breakeven target. Utilization at 22% remains below the 40%-50% Q4 FY27 target.

What is Aequs's aerospace order book and when will it be delivered?

The aerospace order book stood at USD 1,004 Mn at Q1 FY27, up 13% QoQ and past USD 1 billion. Management confirmed the USD 814 Mn figure disclosed earlier was total contract value to be delivered between now and 2031, and said new wins including the Safran wheels contract will reflect in the next quarter's order book.

How will Aequs fund its FY27 capex of Rs. 660 crore?

FY27 capex of Rs. 660 crores — Rs. 500 Cr consumer electronics and Rs. 160 Cr aerospace — is to be funded via borrowings and internal accruals. Management also noted that if consumer utilization does not materialize, some portion of the consumer capex will not happen.

What are Aequs's ROCE targets for capital allocation?

Management has stated its steady-state ROCE targets remain 18% to 20% for capital allocation. The Vision 2031 roadmap also sets a 20% steady-state ROCE alongside an 18%-22% EBITDA margin.

Powered by Cofacto — AI research platform for Indian stocks, every claim cited from primary filings

Login Now